Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristina Chelleri

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Lasers in Surgery and Medicine|December 13, 2019
Residual Lesions After Pharmacological and Dye-Laser Treatment of Infantile Hemangiomas: Critical Review of 432 CasesCristina Chelleri, Nicola Adriano Monzani, Carlo Gelmetti, et al.
Cancers|May 14, 2025
Café-Au-Lait Macules in Neurofibromatosis Type 1: Birthmark or Biomarker?Andrea Santangelo, Cristina Chelleri, Marco Tomasino, et al.
Journal of Clinical Medicine|March 28, 2024
Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic ManagementPaola Borgia, Gianluca Piccolo, Andrea Santangelo, et al.
Frontiers in Pediatrics|March 16, 2023
Case report: Revascularization failure in NF1-related moyamoya syndrome after selumetinib: A possible pathophysiological correlation?Cristina Chelleri, Marcello Scala, Patrizia De Marco, et al.
American Journal of Medical Genetics. Part A|July 20, 2024
Novel causative variants in Legius syndrome: SPRED1 Genotype spectrum expansionCristina Chelleri, Noemi Brolatti, Patrizia De Marco, et al.
Cancers|March 29, 2023
Moyamoya Vasculopathy in Neurofibromatosis Type 1 Pediatric Patients: The Role of Rare Variants of <i>RNF213</i>Marzia Ognibene, Marcello Scala, Michele Iacomino, et al.
Human Mutation|April 14, 2025
Somatic Double Inactivation of <i>NF1</i> Associated with NF1-Related Pectus Excavatum DeformityCristina Chelleri, Marcello Scala, Patrizia De Marco, et al.
Cancers|April 30, 2021
Genotype-Phenotype Correlations in Neurofibromatosis Type 1: A Single-Center Cohort StudyMarcello Scala, Irene Schiavetti, Francesca Madia, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Lasers in Surgery and Medicine|December 13, 2019
Residual Lesions After Pharmacological and Dye-Laser Treatment of Infantile Hemangiomas: Critical Review of 432 CasesCristina Chelleri, Nicola Adriano Monzani, Carlo Gelmetti, et al.
Cancers|May 14, 2025
Café-Au-Lait Macules in Neurofibromatosis Type 1: Birthmark or Biomarker?Andrea Santangelo, Cristina Chelleri, Marco Tomasino, et al.
Journal of Clinical Medicine|March 28, 2024
Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic ManagementPaola Borgia, Gianluca Piccolo, Andrea Santangelo, et al.
Frontiers in Pediatrics|March 16, 2023
Case report: Revascularization failure in NF1-related moyamoya syndrome after selumetinib: A possible pathophysiological correlation?Cristina Chelleri, Marcello Scala, Patrizia De Marco, et al.
American Journal of Medical Genetics. Part A|July 20, 2024
Novel causative variants in Legius syndrome: SPRED1 Genotype spectrum expansionCristina Chelleri, Noemi Brolatti, Patrizia De Marco, et al.
Cancers|March 29, 2023
Moyamoya Vasculopathy in Neurofibromatosis Type 1 Pediatric Patients: The Role of Rare Variants of <i>RNF213</i>Marzia Ognibene, Marcello Scala, Michele Iacomino, et al.
Human Mutation|April 14, 2025
Somatic Double Inactivation of <i>NF1</i> Associated with NF1-Related Pectus Excavatum DeformityCristina Chelleri, Marcello Scala, Patrizia De Marco, et al.
Cancers|April 30, 2021
Genotype-Phenotype Correlations in Neurofibromatosis Type 1: A Single-Center Cohort StudyMarcello Scala, Irene Schiavetti, Francesca Madia, et al.
Pageof 1